Literature DB >> 23594093

Hyperbranched dendritic nano-carriers for topical delivery of dithranol.

Udita Agrawal1, Neelesh Kumar Mehra, Umesh Gupta, N K Jain.   

Abstract

The purpose of the current investigation was to explore the potential of polypropylene imine (PPI) dendrimers to deliver dithranol (DIT) topically and to evaluate its encapsulation, permeation and skin irritation potential. PPI (5.0 generation, 5.0 G) dendrimers and DIT-loaded PPI (DIT-PPI) were prepared and characterized by spectroscopy and transmission electron microscopy. DIT encapsulation, in vitro skin permeation study, skin irritation studies, fluorescent studies and tape stripping studies were performed. Loading of DIT was found to be pH dependent with maximum encapsulation at acidic pH (1.0 ± 0.02, 17.2 ± 0.56 and 57.1 ± 1.32% at 7.4, 5.5 and 1.2 pH, respectively). DIT-PPI showed significantly enhanced permeation rate constant and lesser skin irritation (11.61 ± 1.80 μg/cm(2)/h and 1.0, respectively) when compared with the plain DIT solution (2.72 ± 0.31 μg/cm(2)/h and 2.3, respectively). Skin separation studies and confocal laser scanning microscope images showed that the dye-loaded dendrimers exhibits deposition of dye in pilosebaceous compartment. These studies demonstrate that PPI can be exploited to improve the topical bioavailability of the molecules in a controlled pattern. The enhanced accumulation of DIT via dendrimer carrier within the skin might help optimize targeting of this drug to the epidermal and dermal sites, thus creating new opportunities for well-controlled, modern topical application of DIT for the treatment of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23594093     DOI: 10.3109/1061186X.2013.771778

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  8 in total

1.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

2.  Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential.

Authors:  Nishi Mody; Rakesh Kumar Tekade; Neelesh Kumar Mehra; Prashant Chopdey; Narendra Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2014-01-16       Impact factor: 3.246

Review 3.  Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.

Authors:  Prativa Biswasroy; Deepak Pradhan; Biswakanth Kar; Goutam Ghosh; Goutam Rath
Journal:  AAPS PharmSciTech       Date:  2021-05-26       Impact factor: 3.246

4.  Herbal ethosomal gel containing luliconazole for productive relevance in the field of biomedicine.

Authors:  Vivek Dave; Nishant Bhardwaj; Nikita Gupta; Kajal Tak
Journal:  3 Biotech       Date:  2020-02-06       Impact factor: 2.406

5.  An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis.

Authors:  Ranime Jebbawi; Abdelouahd Oukhrib; Emily Clement; Muriel Blanzat; Cédric-Olivier Turrin; Anne-Marie Caminade; Eric Lacoste; Séverine Fruchon; Rémy Poupot
Journal:  Biomolecules       Date:  2020-06-23

6.  Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients.

Authors:  Dina Fathalla; Eman M K Youssef; Ghareb M Soliman
Journal:  Pharmaceutics       Date:  2020-05-11       Impact factor: 6.321

Review 7.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.

Authors:  Ana M Martins; Andreia Ascenso; Helena Margarida Ribeiro; Joana Marto
Journal:  Mol Neurobiol       Date:  2020-02-15       Impact factor: 5.590

Review 8.  Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.

Authors:  Robert Gironés Petit; Amanda Cano; Alba Ortiz; Marta Espina; Josefina Prat; Montserrat Muñoz; Patrícia Severino; Eliana B Souto; Maria L García; Montserrat Pujol; Elena Sánchez-López
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.